Fundamental Analysis of Thermo Fisher Scientific Inc - Growth / Value Index
TMO - Valuation Highlights
Valuation Analysis
Undervalued - Price to Intrinsic Value of 0.326
Book Value in last 3 years is trending up
Tsr Value Index - Very Poor Score of 17.19
Price to Book Ratio of 5.14 suggesting that it is very expensive
Valuation Key Ratios
| Ratio | TTM | Latest FY | Yoy Change | MRQ |
|---|---|---|---|---|
| Price to Earning | 37.43 | 38.88 | 15.20 % | |
| Price to Book | 5.14 | 4.93 | -7.43 % | 5.02 |
| Price to Sales | 5.42 | 5.32 | 1.87 % | |
| Enterprise Value to EBITDA Multiple | 31.15 | 24.30 | 9.69 % |
TMO - Profitability Highlights
Profitability Analysis
Piotroski F Score - Good Value of 7.0
Company Earning excess return
Good Return on Equity of 13.76% is achieved by the company
Good Net Margin of 14.49% is achieved by the company
Tsr Profitability Index - Poor Score of 27.50
Very Low Dividend Yield of 0.260 %
Low Earning Yield of 2.67 %
EPS decline for last four quarters
Profitability Key Ratios
| Ratio | TTM | Latest FY | Yoy Change | MRQ |
|---|---|---|---|---|
| Return On Equity | 13.76 | 12.72 | -19.44 % | 2.92 |
| Return On Asset | 6.39 | 6.02 | -15.76 % | 1.37 |
| Net Profit Margin | 14.49 | 13.68 | -11.58 % | 12.84 |
| Operating Profit Margin | 16.09 | 16.81 | -10.03 % | 16.08 |
| EBITDA Margin | 19.19 | 24.44 | -6.67 % | 16.08 |
Highlights
| Market Cap | 227235 M |
| Enterprise Value | 254075 M |
| Price/Book TTM | 5.14 |
| Outstanding Share | 381716 K |
| Float/ Outstanding Share | 99.76% |
| Dividend Yield | 0.260 % |
Share Holding
Guru Numbers
| Price/Graham No | 2.86 |
| Peter Lynch Ratio | -0.352 |
| Piotroski F Score | 7.00 |
| Altman Z Score | 4.11 |
| Sloan Ratio | -0.0226 |
| Peter Lynch Fair Value | 180.64 |
TMO - Growth Highlights
Growth Analysis
Steady increase in Total Assets for last 3 Years
Tsr Growth Index - Poor Score of 34.14
Quarterly sales in last 5 Quarter is trending down
Operating Cash Flow decreasing for last 3 year
Growth Key Fields
| Field | TTM | YoY Growth | QoQ Growth |
|---|---|---|---|
| Revenue | 42492.00 M | 3.33 % | 4.97 % |
| Gross Profit | 17594.00 M | 11.22 % | 4.25 % |
| EBITDA | 8156.00 M | 9.78 % | 10.30 % |
| Net Profit | 6155.00 M | 14.52 % | 18.53 % |
| EPS | 15.90 | 13.20 % | NA |
TMO - Stability Highlights
Stability Analysis
Altman Z Score of 4.11 suggests good Stability
Stability Key Ratios
| Ratio | Latest FY | Yoy Change | MRQ |
|---|---|---|---|
| Debt to Equity Ratio | 0.747 | -4.59 % | 0.783 |
| Cash Ratio | 0.576 | 15.73 % | |
| Quick Ratio | 1.39 | 20.71 % | 1.33 |
| Shareholders Equity | 47.33 | 4.57 % | |
| Debt to EBITDA | 3.29 | 12.22 % |
Historical Valuation Ratios of Thermo Fisher Scientific Inc
Historical Valuation Ratios
Loading ...
Historical Profitability Ratios of Thermo Fisher Scientific Inc
Historical Profitability Ratios
Loading ...
Historical Efficiency Ratios of Thermo Fisher Scientific Inc
Historical Efficiency Ratios
Loading ...
Historical Solvency Ratios of Thermo Fisher Scientific Inc
Historical Solvency Ratios
Loading ...
Note : All Data Generated at the End of Trading Hours (EOD Data)